cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Relmada Therapeutics Inc
4 own
3 watching
Current Price
$4.65
$-0.01
(-0.21%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
102.94M
52-Week High
52-Week High
7.22300
52-Week Low
52-Week Low
2.34000
Average Volume
Average Volume
0.12M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization102.94M
icon52-Week High7.22300
icon52-Week Low2.34000
iconAverage Volume0.12M
iconDividend Yield--
iconP/E Ratio--
What does the Relmada Therapeutics Inc do?
Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing various products for the treatment of central nervous system (CNS) diseases and other disorders. Its lead product candidate is Esmethadone (d-methadone, dextromethadone, and REL-1017), a new chemical entity and N-methyl-D-aspartate receptor antagonist that is in Phase 3 clinical trials for the adjunctive or monotherapy treatment of major depressive disorder in adults. The company was founded in 2004 and is headquartered in Coral Gables, Florida.
Read More
How much money does Relmada Therapeutics Inc make?
News & Events about Relmada Therapeutics Inc.
Globe Newswire
9 months ago
NEW YORK, July 01, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Seagate Technology...
Globe Newswire
9 months ago
NEW YORK, June 25, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Relmada Therapeutics, Inc. (NYSE: RLMD), DoubleVerify Holdings, Inc. (NYSE: DV), Sanmina Corporation (NASDAQ: SANM), and JinkoSolar ...
Globe Newswire
9 months ago
NEW YORK, June 19, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Waldencast Plc (NASDAQ: WALD), Seagate Technology Holdings Plc (NASDAQ: STX), Chegg, Inc. (NYSE: CHGG), and Relmada Therapeutics, ...
PR Newswire
11 months ago
RLMD FRAUD ALERT: Jakubowitz Law is Investigating Relmada Therapeutics, Inc. in Connection with Potential Violations of Federal Securities Laws RLMD FRAUD ALERT: Jakubowitz Law is Investigating Relmada Therapeutics, Inc. in Connection with Potential Violations of Federal Securities Laws PR Newswire...
PR Newswire
11 months ago
RLMD INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by Officers of Relmada Therapeutics, Inc. RLMD INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Investors of an Investigation Involving Possible Securities...
Frequently Asked Questions
Frequently Asked Questions
What is Relmada Therapeutics Inc share price today?
plus_minus_icon
Can Indians buy Relmada Therapeutics Inc shares?
plus_minus_icon
How can I buy Relmada Therapeutics Inc shares from India?
plus_minus_icon
Can Fractional shares of Relmada Therapeutics Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Relmada Therapeutics Inc stocks?
plus_minus_icon
What is today’s traded volume of Relmada Therapeutics Inc?
plus_minus_icon
What is today’s market capitalisation of Relmada Therapeutics Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Relmada Therapeutics Inc?
plus_minus_icon
What percentage is Relmada Therapeutics Inc down from its 52-Week High?
plus_minus_icon
What percentage is Relmada Therapeutics Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$4.65
$-0.01
(-0.21%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00